Kymera Therapeutics, Inc. (KYMR) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $39.21M | -16.7% |
| 2024 | $47.07M | -40.1% |
| 2023 | $78.59M | +67.8% |
| 2022 | $46.83M | -35.7% |
| 2021 | $72.83M | +114.0% |
| 2020 | $34.03M | +1060.0% |
| 2019 | $2.93M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $39.21M | -16.7% |
| 2024 | $47.07M | -40.1% |
| 2023 | $78.59M | +67.8% |
| 2022 | $46.83M | -35.7% |
| 2021 | $72.83M | +114.0% |
| 2020 | $34.03M | +1060.0% |
| 2019 | $2.93M | — |